Table 2.
Comparison of the different studied groups with regard to alpha-fetoprotein and annexin A21
| Parameter |
HCC vs control |
CLD vs control |
HCC vs CLD |
|||
| Z value | P value | Z value | P value | Z value | P value | |
| AFP (ng/mL) | -5.006 | < 0.012 | -3.4 | < 0.012 | -4.17 | < 0.012 |
| ANXA2 (ng/mL) | -3.5 | < 0.012 | -1.6 | > 0.05 | -4.8 | < 0.012 |
1
Wilcoxon Rank Sum test (non-parametric data);
2
Statistically significant difference. AFP: Alpha-fetoprotein; ANXA2: Annexin A2; HCC: Hepatocellular carcinoma; CLD: Chronic liver disease.